The media have been building up “eyeball jewelry” as a potential craze, but the evidence suggests otherwise

Gene therapy for ocular disease will soon be available. Stem cell therapies too. They may be able to cure the currently untreatable, but at what price? And will anyone pay it?

Who should receive ILUVIEN® for the treatment of chronic DME-associated vision impairment

Expert opinion: infection prevention & treatment in photorefractive surgery patients.

Jim discusses his background, leadership style and his vision for Oraya's future with us.

Patients need to know what their ophthalmologist actually ‘does’, and what to expect when they are referred.

Market research requires that you examine three things: customers, the competition and the environment.

The last decade has seen some great advances, but there's still room for improvement…

Predicting treatment outcomes manages their expectations and improves your care.

Therapies based on stem cell treatments are considered to have tremendous potential in medicine.